PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, offering promising breakthroughs across different medical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, extra trustworthy alternative for therapeutic use, not